Know Cancer

or
forgot password

A Prestudy of Impact of Cytokines and Gene Expression on Outcome of IVF


N/A
23 Years
35 Years
Open (Enrolling by invite only)
Female
Endometrial Receptivity and Success Rate of IVF

Thank you

Trial Information

A Prestudy of Impact of Cytokines and Gene Expression on Outcome of IVF


The study will be performed

in the Cairo IVE Unit; Faculty of medicine Cairo University on 15 cases. Inclusion criteria:
age 23 -35, FSH less than 10 no previous uterine operations, no history of poor response
in previous IVF no sever male factor no endometriosis and uterine factor are excluded .
no diabetes mellitus and antral follicle count (AFC) > 5 undergoing IVF using standard long
protocol.

All patients will give their informed consent to participate in the study. Endometrial
tissue samples will be taken on the day of oocyte retrieval using soft suction plastic
catheter. The menstrual blood of 10 women with regular menstrual cycles and with no apparent
endometrial dysfunction was taken as control samples. The study protocol and informed
consents were approved by the Human Ethics Committee of IVF department .of Kasar Ini
hospital

Total RNA isolation: Endometrial biopsies and menstrual control blood will be lysed by RLT
buffer (QIAGEN, Germantown, MD). The lysates further prepared for total RNA extraction
using the RNeasy mini kit (QIAGEN, Germantown, MD) according to the manufacturer's
instructions. The RNA extract stored at -80ºC until future use. RNA purity, yield, and
concentration will be determined through dual spectrophotometry (Beckman, USA), and 1μg of
RNA run on a 1% agarose gel (Roche, Castle Hill, Australia) to ensure integrity of the RNA.
Quantitative RT-PCR (qRT-PCR): Reverse transcriptase (RT) reaction mixture using High
Capacity Reverse Transcriptase kit (Applied Biosystems, USA) containing: 1 μg total RNA from
each sample for cDNA synthesis, 0.5 μg random primer, 5×RT buffer, 2.5 mmol/L dNTP, 20 U
RNase inhibitor and 200 U MMLV reverse transcriptase in a total volume of 25 μl was
incubated at 37ºC for 60 minutes, then heated to 95 ºC for 5 minutes to inactivate MMLV. RT
will be followed by qPCR, 50 ng of cDNA were added to 5 X Fast-Start SYBR green master mix
with Rox (Roche Diagnostics, Indianapolis, IN) and 200 ng of primer mix (Sigma). The
reaction will be carried out in micro optical plates (Applied Biosystems) and analyzed using
StepOne real-time 203 PCR system (Applied Biosystems). The PCR running method was as
follows: 10 minutes at 950C for enzyme activation followed by 40 cycles of 15 seconds at
950C, 20 seconds at 550C and 30 second at 720C for the amplification step. The primers used
in the qRT-PCR evaluation specific for target genes (table 1). Relative mRNA expression
will be calculated by the comparative cycle threshold method . as outlined in the
manufacturer's user manual with GAPDH house-keeping gene. The fluorescence was plotted
versus PCR cycle number for reaction and each sample indicated. Serum hormonal levels
assay: FSH, LH and E2 were estimated by ELISA according to instructions of manufacturers.
DNA purification and sequencing analysis: IL-11 and LIF genes analyzed by direct
sequencing of the PCR products using SEQr kit. (Applied Biosystems), according to
manufacturer's protocol. PCR products will be purified using the QIAquick Gel Extraction Kit
(QIAGEN). The relevant purified DNA samples of all the cases and controls will be amplified
and sequenced using automated sequencing with the aid of a Big Dye Terminator Sequencing Kit
(PE/Applied Biosystems, Foster City, CA). The samples will be run in an automated sequencer
ABI Prism 310 Avant (PE/Applied Biosystems).. All samples will be sequenced twice to ensure
the results.

Statistical analysis: Data will be statistically described in terms of mean standard
deviation , median and range. Comparison between women who could achieve pregnancy and those
who didn't was done using Mann Whitney U test for independent samples. Correlation between
various variables was done using Spearman rank correlation equation for non-normal
variables.


Inclusion Criteria:



- FSH LESS THAN 10 ,

Exclusion Criteria:

NO SEVER MALE FACTOR no endometriosis , DM or previous uterine surgery .

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

relation between IL11 AND IL6 PRESENCE AND GENE EXPRESSION AND SUCCESS OF IVF

Outcome Time Frame:

one year

Safety Issue:

No

Authority:

Egypt : faculty of medicine cairo university

Study ID:

FDAAA

NCT ID:

NCT01809509

Start Date:

January 2012

Completion Date:

November 2013

Related Keywords:

  • Endometrial Receptivity and Success Rate of IVF
  • CYTOKINES , IL11 IL6 IMLANTATION RATE IVF.
  • Adenoma

Name

Location